104 related articles for article (PubMed ID: 22026134)
1. Intratympanic lidocaine instillation for Menière's disease.
Verdonck J; Desloovere C
B-ENT; 2011; 7(3):157-64. PubMed ID: 22026134
[TBL] [Abstract][Full Text] [Related]
2. Labyrinth anesthesia--a forgotten but practical treatment option in Ménière's disease.
Adunka O; Moustaklis E; Weber A; May A; von Ilberg C; Gstoettner W; Kierner AC
ORL J Otorhinolaryngol Relat Spec; 2003; 65(2):84-90. PubMed ID: 12824729
[TBL] [Abstract][Full Text] [Related]
3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
5. Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.
Nedzelski JM; Chiong CM; Fradet G; Schessel DA; Bryce GE; Pfleiderer AG
Am J Otol; 1993 May; 14(3):278-82. PubMed ID: 8372926
[TBL] [Abstract][Full Text] [Related]
6. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
[TBL] [Abstract][Full Text] [Related]
7. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
8. Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventory.
Banerjee AS; Johnson IJ
J Laryngol Otol; 2006 Oct; 120(10):827-31. PubMed ID: 16707038
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
[TBL] [Abstract][Full Text] [Related]
10. Intratympanic steroid injections for intractable Ménière's disease.
Barrs DM; Keyser JS; Stallworth C; McElveen JT
Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease.
De Stefano A; Dispenza F; De Donato G; Caruso A; Taibah A; Sanna M
Am J Otolaryngol; 2007; 28(5):289-93. PubMed ID: 17826528
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic gentamicin for Menière's disease: a meta-analysis.
Cohen-Kerem R; Kisilevsky V; Einarson TR; Kozer E; Koren G; Rutka JA
Laryngoscope; 2004 Dec; 114(12):2085-91. PubMed ID: 15564826
[TBL] [Abstract][Full Text] [Related]
13. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
Martin Sanz E; Zschaeck C; Gonzalez M; Mato T; Rodrigañez L; Barona R; Sanz R
Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
[TBL] [Abstract][Full Text] [Related]
14. Effects of endolymphatic sac drainage with steroids for intractable Meniere's disease: a long-term follow-up and randomized controlled study.
Kitahara T; Kubo T; Okumura S; Kitahara M
Laryngoscope; 2008 May; 118(5):854-61. PubMed ID: 18520184
[TBL] [Abstract][Full Text] [Related]
15. Intratympanic gentamicin injection for the treatment of Meniere's disease.
Youssef TF; Poe DS
Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
Kaplan DM; Nedzelski JM; Chen JM; Shipp DB
Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
[TBL] [Abstract][Full Text] [Related]
17. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
Silverstein H; Isaacson JE; Olds MJ; Rowan PT; Rosenberg S
Am J Otol; 1998 Mar; 19(2):196-201. PubMed ID: 9520056
[TBL] [Abstract][Full Text] [Related]
19. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
Weckel A; Marx M; Esteve-Fraysse MJ
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
